Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma

NCT02197637 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT02197637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02197637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Lead sponsor
Centre Oscar Lambret
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2014
Completion date
October 31, 2020
Enrollment
39 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

low-grade glioma